Cargando…
First person – Matt Johansen
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Matt Johansen is first author on ‘ Mycobacteriophage–antibiotic therapy promotes enhanced c...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461819/ http://dx.doi.org/10.1242/dmm.049238 |
_version_ | 1784572069305909248 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Matt Johansen is first author on ‘ Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus’, published in DMM. Matt completed the research described in this article while a postdoc in the lab of Laurent Kremer at Institut de Recherche en Infectiologie de Montpellier, Montpellier, France, and is now a postdoc in the lab of Phil Hansbro at the Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia, investigating the disease pathogenesis of infectious organisms and deciphering host–pathogen interactions. |
format | Online Article Text |
id | pubmed-8461819 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-84618192021-09-24 First person – Matt Johansen Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Matt Johansen is first author on ‘ Mycobacteriophage–antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus’, published in DMM. Matt completed the research described in this article while a postdoc in the lab of Laurent Kremer at Institut de Recherche en Infectiologie de Montpellier, Montpellier, France, and is now a postdoc in the lab of Phil Hansbro at the Centre for Inflammation, Centenary Institute and University of Technology Sydney, Sydney, Australia, investigating the disease pathogenesis of infectious organisms and deciphering host–pathogen interactions. The Company of Biologists Ltd 2021-09-17 /pmc/articles/PMC8461819/ http://dx.doi.org/10.1242/dmm.049238 Text en © 2021. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Matt Johansen |
title | First person – Matt Johansen |
title_full | First person – Matt Johansen |
title_fullStr | First person – Matt Johansen |
title_full_unstemmed | First person – Matt Johansen |
title_short | First person – Matt Johansen |
title_sort | first person – matt johansen |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461819/ http://dx.doi.org/10.1242/dmm.049238 |